Product
Liposomal ARA-C
1 clinical trial
7 indications
Indication
Non-Hodgkin lymphomaIndication
Burkitt lymphomaIndication
Diffuse Large B-Cell LymphomaIndication
Primary Mediastinal B-cell LymphomaIndication
B-Lymphoblastic LymphomaIndication
Follicular LymphomaIndication
Grade IIIClinical trial
Chemoimmunotherapy With Obinutuzumab, Ifosfamide, Carboplatin and Etoposide (O-ICE) in Children, Adolescents and Young Adults With Recurrent Refractory CD20+ Mature B-NHLStatus: Recruiting, Estimated PCD: 2024-12-01